Ethical Issues in Neonatal and Pediatric Clinical Trials

Pediatric Clinics of North America

Volumn 59, Issue 5, 2012, Pages 1205-1220

  Laventhal, Naomi ^a   Tarini, Beth A ^a   Lantos, John ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Clinical trials; Ethics; Genetic testing; Hypoxic ischemic encephalopathy; Informed consent; Risk benefit assessment; Stem cell transplantation

Indexed keywords

CHILD SAFETY; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); DONOR SELECTION; ETHICAL DECISION MAKING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; NEWBORN CARE; NONHUMAN; PRACTICE GUIDELINE; RESEARCH ETHICS; REVIEW; RISK BENEFIT ANALYSIS; SIBLING; STEM CELL TRANSPLANTATION; VULNERABLE POPULATION;

CHILD; CLINICAL TRIALS AS TOPIC; ETHICS, MEDICAL; FEDERAL GOVERNMENT; GUIDELINES AS TOPIC; HUMANS; INFANT, NEWBORN; INFORMED CONSENT; PEDIATRICS; RISK ASSESSMENT; UNITED STATES;

EID: 84867087849     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2012.07.007     Document Type: Review

References (50)

1. Beecher H.K. Ethics and clinical research. N Engl J Med 1966, 274(24):1354-1360.
2. Ramsey P. The patient as person; explorations in medical ethics 1970, Yale University Press, New Haven (CT).
3. Goldby S. Experiments at the Willowbrook State School. Lancet 1971, 297(7702):749.
4. Krugman S. Experiments at the Willowbrook State School. Lancet 1971, 1(7706):966-967.
5. Prevention of viral hepatitis: mission impossible?. JAMA 1971, 217(1):70-71.
6. Rothman D.J. Were Tuskegee & Willowbrook 'studies in nature'?. Hastings Cent Rep 1982, 12(2):5-7.
7. Steinbrook R. Testing medications in children. N Engl J Med 2002, 347(18):1462-1470.
8. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Report and recommendations on research involving children. Washington, DC: US Government Printing Office; 1977.
9. United State National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research Research involving children: report and recommendations 1977, The Commission, Bethesda (MD).
10. Westra A.E., Wit J.M., Sukhai R.N., et al. How best to define the concept of minimal risk. J Pediatr 2011, 159(3):496-500.
11. Shah S., Whittle A., Wilfond B., et al. How do institutional review boards apply the federal risk and benefit standards for pediatric research?. JAMA 2004, 291(4):476-482.
12. Jonsen A.R. Research involving children: recommendations of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Pediatrics 1978, 62(2):131-136.
13. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987, 317(3):141-145.
14. Bartholome W. Ethical issues in pediatric research. The ethics of research involving human subjects 1996, 360-361. University Publishing Group, Frederick (MD). H.Y. Vanderpool (Ed.).
15. Roth-Cline M., Gerson J., Bright P., et al. Ethical considerations in conducting pediatric research 1st Edition. Handb Exp Pharmacol 2011, 205:219-244.
16. Unguru Y., Sill A.M., Kamani N. The experiences of children enrolled in pediatric oncology research: implications for assent. Pediatrics 2010, 125(4):e876-e883.
17. Whittle A., Shah S., Wilfond B., et al. Institutional review board practices regarding assent in pediatric research. Pediatrics 2004, 113(6):1747-1752.
18. Human subjects research protections: enhancing protections for research subjects and reducing burden, delay, and ambiguity for investigators; advance notice of proposed rulemaking. Fed Regist 2011, 76(143):44512-44531.
19. Stark A.R., Tyson J.E., Hibberd P.L. Variation among institutional review boards in evaluating the design of a multicenter randomized trial. J Perinatol 2010, 30(3):163-169.
20. Ross L.F., Moon M.R. Ethical issues in genetic testing of children. Arch Pediatr Adolesc Med 2000, 154(9):873-879.
21. Martin D.M., Probst F.J., Camper S.A., et al. Characterisation and genetic mapping of a new X linked deafness syndrome. J Med Genet 2000, 37(11):836-841.
22. Mefford H.C. Genotype to phenotype-discovery and characterization of novel genomic disorders in a " genotype-first" era. Genet Med 2009, 11(12):836-842.
23. Lehmann A., Speight B.S., Kerzin-Storrar L. Extended family impact of genetic testing: the experiences of X-linked carrier grandmothers. J Genet Couns 2011, 20(4):365-373.
24. Tabor H.K., Cho M.K. Ethical implications of array comparative genomic hybridization in complex phenotypes: points to consider in research. Genet Med 2007, 9(9):626-631.
25. Teplick A., Kowalski M., Biegel J.A., et al. Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician. Eur J Pediatr 2011, 170(3):285-294.
26. Wilfond B., Ross L.F. From genetics to genomics: ethics, policy, and parental decision-making. J Pediatr Psychol 2009, 34(6):639-647.
27. Nelson R.M., Botkjin J.R., Kodish E.D., et al. Ethical issues with genetic testing in pediatrics. Pediatrics 2001, 107(6):1451-1455.
28. Davis D.S. Genetic dilemmas and the child's right to an open future. Rutgers Law J 1997, 28:549-592.
29. Wertz D.C., Fanos J.H., Reilly P.R. Genetic testing for children and adolescents. Who decides?. JAMA 1994, 272(11):875-881.
30. Wade C.H., Wilfond B.S., McBride C.M. Effects of genetic risk information on children's psychosocial wellbeing: a systematic review of the literature. Genet Med 2010, 12(6):317-326.
31. Tarini B.A., Tercyak K.P., Wilfond B.S. Commentary: children and predictive genomic testing: disease prevention, research protection, and our future. J Pediatr Psychol 2011, 36(10):1113-1121.
32. Committee on Bioethics Children as hematopoietic stem cell donors. Pediatrics 2010, 125(2):392-404.
33. Pulsipher M.A., Nagler A., Iannone R., et al. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 2006, 46(4):422-433.
34. Summary PESM. 2008. Available at: Accessed April 24, 2012. http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4406s1-01.pdf.
35. Gunn A.J., Gluckman P.D., Gunn T.R. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics 1998, 102(4):885-892.
36. Shankaran S., Laptook A., Wright L., et al. Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants. Pediatrics 2002, 110(2):377-385.
37. Jacobs S., Hunt R., Tarnow-Mordi W., et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2007, (4). CD003311.
38. Blackmon L.R., Stark A.R., American Academy of Pediatrics Committee on Fetus and Newborn Hypothermia: a neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy. Pediatrics 2006, 117(3):942-948.
39. Papile L.A. Systemic hypothermia - A " cool" therapy for neonatal hypoxic-ischemic encephalopathy. N Engl J Med 2005, 353(15):1619-1620.
40. Schulzke S., Rao S., Patole S. A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy - are we there yet?. BMC Pediatr 2007, 7(1):30.
41. Kirpalani H., Barks J., Thorlund K., et al. Cooling for neonatal hypoxic ischemic encephalopathy: do we have the answer?. Pediatrics 2007, 120(5):1126-1130.
42. Wilkinson D., Casalaz D., Watkins A., et al. Hypothermia: a neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy. Pediatrics 2007, 119(2):422-423.
43. Gunn A., Hoehn T., Hansmann G., et al. Hypothermia: an evolving treatment for neonatal hypoxic ischemic encephalopathy. Pediatrics 2008, 121(3):648-649.
44. Raghuveer T.S., Cox A.J. Neonatal resuscitation: an update. Am Fam Physician 2011, 83(8):911-918.
45. Hoehn T., Hansmann G., Bhrer C., et al. Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units. Resuscitation 2008, 78(1):7-12.
46. Roehr C.C., Hansmann G., Hoehn T., et al. The 2010 guidelines on neonatal resuscitation (AHA, ERC, ILCOR): similarities and differences - what progress has been made since 2005?. Klin Padiatr 2011, 223(5):299-307.
47. Barks J.D. Technical aspects of starting a neonatal cooling program. Clin Perinatol 2008, 35(4):765-775.
48. Jacobs S.E., Morley C.J., Inder T.E., et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med 2011, 165(8):692-700.
49. Wyatt J.S. Ethics and hypothermia treatment. Semin Fetal Neonatal Med 2010, 15(5):299-304.
50. Assmann S.F., Pocock S.J., Enos L.E., et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000, 355(9209):1064-1069.